Biotech Startups

Kinomica develops mass spectrometry-based diagnostic tests that measure protein activity to predict patient responses to multiple drugs. The company aims to advance precision medicine by enabling companion diagnostics that help match patients to appropriate therapeutic options.

1 investor

1 investor

Kling Biotherapeutics develops antibody therapeutics by discovering novel targets and fully human antibodies directly from patient-derived B cells, with a focus on oncology and infectious diseases. Its pipeline includes KBA1412, a first-in-class CD9 antibody in Phase 1 clinical testing.

1 investor

Klotho Therapeutics is a biotech company developing protein-based therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney disease, diabetes, and cancer. The company focuses on longevity treatment and aims to enter human trials within two years targeting kidney disease.

1 investor

Klyne develops binding affinity models for molecular prediction and offers a low-cost virtual screening service aimed at hit discovery and hit-to-lead optimization projects in drug discovery labs. It targets companies working on early-stage pharmaceutical research with limited budgets.

1 investor

Kobuk Therapeutics is developing a biologics platform aimed at treating autoimmune diseases by resetting the immune system to a healthy state while preserving protective immunity.

1 investor

The Köttermann Group is a coalition of European manufacturers providing laboratory infrastructure and Design/Build solutions for laboratories worldwide, serving both public and commercial sectors. It operates as a holding structure coordinating its member companies and is part of the private investment firm BHM group.

1 investor

The company uses cellular agriculture and bio-technology to isolate cells from premium cacao strains, culture them in optimized conditions, upscale biomass in bioreactors, and process cocoa for various applications.

1 investor

KolateAI provides AI-driven software solutions to optimize the drug development process, including clinical trials and real-world studies. The platform serves pharmaceutical companies and research organizations seeking to improve efficiency and accelerate drug development timelines.

1 investor

1 investor

Kompass Diagnostics is developing a rapid point-of-care hormone testing platform that uses a cartridge-based analyzer to quantify hormone levels quickly and store results in EHR systems. Its tests target fertility, reproductive, and thyroid monitoring for clinics, satellite locations, Ob/Gyn providers, and diagnostic centers.

1 investor

KORSUVA is a prescription medicine that treats moderate-to-severe itching associated with chronic kidney disease in adults undergoing hemodialysis. The product is marketed by Vifor (International) Inc.

1 investor

KOTAI Biotechnologies develops an immune AI platform and big data analysis pipeline that combines artificial intelligence with immunology for antibody and immune-repertoire analysis. The company serves pharmaceutical and life-science research applications such as antibody modeling, single-cell analysis, and cancer and infectious-disease immunology research.

1 investor

Kraken Sense develops automated, real-time detection systems for bacterial, viral, and chemical targets along with automated library preparation technology for whole genome, pooled, and metagenomic sequencing. Its qPCR-based systems serve sectors such as water and wastewater, food and beverage, pharmaceuticals, agriculture, and biosurveillance.

1 investor

A bioinformatics company applying genetics and selective breeding methods to livestock, offering genetic analysis for animal husbandry and breeding programs. It serves agricultural and animal-breeding clients.

1 investor

Kutanios develops LIPOXERASE, a skincare technology using biodegradable molecules made from natural amino acids and fats to remove lipid peroxides and other harmful chemicals produced by sunlight, pollution, and tobacco smoke from the skin. The company's science-based products are developed by medical biologists for the cosmetics and skincare market.

1 investor

KymaThera is a biotech company that uses structure-based drug design to develop small molecule therapeutics for cancer and other serious diseases. Its research team focuses on creating differentiated medicines aimed at improving patient outcomes.

1 investor

L7 Informatics builds L7|ESP, a unified digital platform for regulated life sciences that captures and contextualizes scientific and operational data at the point of generation and orchestrates workflows across research, development, manufacturing, and quality. It serves pharmaceutical companies, biotechs, CDMOs, CROs, diagnostics organizations, cancer centers, and research institutions with built-in LIMS, ELN, MES, and scheduling capabilities and an agentic AI layer for GxP-regulated environments.

1 investor

LJL Ventures is an early-stage venture fund that backs AI-driven therapeutics companies applying machine learning, generative biology, and computational chemistry across drug discovery, development, and clinical stages. It invests in founders building AI-native platforms for target identification, IND-enabling studies, and clinical trial design.

1 investor

LabAdvance provides microfluidic systems, pumps, controllers, and chips for building laboratory processes. The company serves researchers and labs developing microfluidic applications.

1 investor

Labbot provides tools designed to help scientists with research and experimental work. The company serves researchers and scientific pioneers working to advance knowledge and improve the world.

1 investor

LabConnect is a central laboratory solutions provider offering program oversight, testing, and support services for clinical research trials worldwide. It serves biopharmaceutical and clinical research clients across therapeutic areas including cell and gene therapy, oncology, and vaccines.

1 investor

LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics. Its internal pipeline focuses on selectivity-enhanced antibodies for treating solid tumours.

1 investor

LabGenomics is a molecular diagnostics and healthcare company providing genetic testing for individuals from pregnant women to newborns, along with personalized microbiome analysis of oral and vaginal flora. It develops disease diagnosis methods and personalized health management services.

1 investor